Search results
- Associated Press Finance via Yahoo
Akebia Therapeutics: Q1 Earnings Snapshot
-based company said it had a loss of 9 cents per share. The kidney disease treatment developer posted revenue of $32.6 million in the period...
4 minutes ago
- Stocks Register
Akebia Therapeutics Inc. (NASDAQ: AKBA) 5.38% Incline Turns Investors Away – Stocks Register
(NASDAQ:AKBA)’s beta value is holding at 0.83, while the average true range (ATR) indicator is currently reading 0.11. An analysis of the Ak...
3 days ago